Journal of the American Heart Association · 2019 · 36 citations · 12 references
MedicineCardiologyClinical CardiologyClinical EpidemiologyInflammationAcute Coronary SyndromesCardiac BiomarkersCardiac Risk AssessmentCardiovascular DiseaseCardiovascular RiskIschemic Heart DiseaseAtherosclerotic Cardiovascular Disease Risk EstimationAtherosclerotic ProgressionAtherosclerotic Risk AssessmentB-type Natriuretic PeptidesC-reactive Protein TestingCox RegressionKaplan-meier Confidence IntervalsKaplan-meier Survival Estimates
Background The involvement of vaspin (visceral adipose tissue-derived serpin) in the development of atherosclerotic cardiovascular diseases has been documented. This study was designed to explore the prognostic value of serum vaspin in patients with acute myocardial infarction ( AMI ). Methods and Results We included 1036 AMI patients in a cohort study and determined the association between serum vaspin and major adverse cardiac events ( MACE ) using Cox regression analysis. The receiver operating characteristic curve indicated that serum vaspin could significantly differentiate patients with MACE , and the optimal cutoff value was 0.62 ng/mL. The Kaplan-Meier survival curve showed that patients with lower vaspin levels had higher incidence of MACE . Multivariate Cox regression analysis revealed that low vaspin was an independent predictor of MACE (hazard ratio: 0.74; 95% CI , 0.48-0.96; P=0.029), together with age; previous histories of AMI , heart failure, hypertension, and diabetes mellitus; Killip class; revascularization; CRP (C-reactive protein); and NT-proBNP (N-terminal pro-B-type natriuretic peptide). Integrated discrimination and net reclassification improvements for MACE were significantly improved by addition of vaspin to the model of traditional risk factors. Moreover, low vaspin was a valuable predictor of heart failure hospitalization (hazard ratio: 0.58; 95% CI , 0.37-0.89; P=0.005) and recurrent AMI (hazard ratio: 0.72; 95% CI , 0.53-0.95; P=0.036) after adjustment for conventional cardiovascular risk factors. Conclusions Our study suggests that serum vaspin is a significant prognostic marker of MACE in AMI patients.
12
Universal Definition of Myocardial Infarction
Kristian Thygesen, Joseph S. Alpert, Harvey D. White · Circulation · 2007 · 4.2K citations
K. Thygesen, Joseph S. Alpert, Harvey D. White et al. · European Heart Journal · 2007 · 2.5K citations · Full text
Serum Vaspin Concentrations in Human Obesity and Type 2 Diabetes
Byung‐Soo Youn, Nora Klöting, Jürgen Kratzsch et al. · Diabetes · 2007 · 421 citations · Full text
Medicine, Endocrinology, Physiology +12